HighVista Strategies is seeking an analyst to join the Public Markets team. This analyst will support the Biotechnology Research efforts the firm has a 13-year history of investing in, with a strong track record of outperformance.
The primary responsibilities of the role will be to execute projects related to the health care sector, with an emphasis on publicly listed biotechnology companies. Projects will be varied and topics will range from being focused on specific companies and disease areas to evaluating specialist investment partners in the space to working on white papers on larger themes within the sector. We value a candidate with fluency in scientific/technical matters while also being an articulate communicator and writer who is able to make complicated topics accessible to a broader audience. The ideal candidate has several years of experience working in industry or as a sell-side research analyst, but we are open to other backgrounds too.
Requirements
HighVista Strategies LLC is an employee-owned alternative asset manager that brings investors alpha opportunities in structurally inefficient markets. Based in Boston and founded in 2004, HighVista manages $11 billion of capital on behalf of sophisticated investors globally. Our culture combines inquisitive thinking with rigorous discipline, enabling us to identify and execute on opportunities with high conviction. HighVista is a partner for investors looking beyond the standard playbook for differentiated ideas that can amplify returns. HighVista’s investment strategies span private markets, including private credit, lower middle market private equity and early-stage venture capital; public markets, including biotechnology equities and hedged public markets strategies; as well as multi-strategy alternatives.
